Skip to main content

Advertisement

Log in

The effects of αGalCer-induced TCRVα24 Vβ11+ natural killer T cells on NK cell cytotoxicity in umbilical cord blood

  • Original Article
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

Purpose

The first objective of this study was to investigate in vitro effects of α-galactosylceramide (αGalCer) on the proliferation of umbilical cord blood (UCB) natural killer T (NKT) cells and enhancement of their cytotoxicity. The second one is to examine whether purified NKT cells could affect the cytotoxicity of UCB-NK cells either in the presence or absence of dendritic cells (DCs).

Methods

Mononuclear cells (MNCs) from UCB were cultured for 2 weeks in the presence of IL-2 (100 U/ml), with or without αGalCer. The effect of neutralizing monoclonal antibodies (MoAb) against TCRVα24 and CD1d was also examined. TCRVα24 Vβ11 double positive NKT cells were purified by FACS sorter and then cocultured with syngeneic isolated UCBCD56+NK cells in either the presence or absence of DCs. The cytotoxicity against various malignant cell targets and cytokine production was determined.

Results

The addition of αGalCer induced human NKT cells to proliferate in UCB-MNCs to a greater extent than in adult PB-MNCs. However, it suppressed the cytotoxic activity against malignant cell targets. Anti-TCRVα24 and CD1d MoAb recovered the cytotoxicity by inhibiting the proliferation of UCB-NKT cells. NKT cells cocultured with auto-DCs significantly increased NK cell cytotoxicity against K562, and Raji cells and produced IFN-γ at much higher levels than UCB-NKT cells alone.

Conclusion

In UCB samples, αGalCer–pulsed DCs and NKT cells acted together to enhance NK cytotoxicity in vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. Nakagawa R, Motoki K, Nakamura H, Ueno H, Iijima R, Yamauchi A, Tsuyuki S, Inamoto T, Koezuka Y (1998) Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production. Oncol Res 10:561

    CAS  PubMed  Google Scholar 

  2. Nakagawa R, Motoki, Ueno H., Iijima R, Nakamura H, Kobayashi E, Shimosaka A, Koezuka Y (1998) Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000. Cancer Res 58:1202

    CAS  PubMed  Google Scholar 

  3. Kawano T, Cui J, Koezuka Y, Toura I., Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M (1997) CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 278:1626

    CAS  PubMed  Google Scholar 

  4. Porcelli SA, Yockey CE, Brenner MB, Balk SP (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4–8-alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 178:1

    CAS  PubMed  Google Scholar 

  5. Brooks EG., Balk SP, Aupeix K, Colonna M, Strominger JL, Groh-Spies V (1993) Human T-cell receptor (TCR) alpha/beta + CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells. Proc Natl Acad Sci USA 90:11787

    CAS  PubMed  Google Scholar 

  6. Kawano T, Tanaka Y, Shimizu E, Kaneko Y, Kamata N, Sato H, Osada H, Sekiya S, Nakayama T., Taniguchi M (1999) A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. Int Immunol 11:881

    Article  CAS  PubMed  Google Scholar 

  7. Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, Akutsu Y, Motohashi S. Iizasa T, Endo H, Fujisawa T, Shinkai H, Taniguchi M (1999) Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res 59:5102

    CAS  PubMed  Google Scholar 

  8. Nieda M, Nicol A, Koezuka Y, Kikuchi A, Takahashi T, Nakamura H, Furukawa H, Yabe T, Ishikawa Y, Tadokoro K, Juji T (1999) Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Hum Immunol 60:10

    Article  CAS  PubMed  Google Scholar 

  9. Nicol A, Nieda M, Koezuka Y, Porcelli S, Suzuki K, Tadokoro K, Durrant S, Juji T (2000) Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic activity: an important immune regulatory function. Exp Hematol 28:276

    CAS  PubMed  Google Scholar 

  10. Nicol A, Nieda M, Koezuka Y, Porcelli S, Suzuki K, Tadokoro K, Durrant S, Juji T (2000) Human invariant Valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells. Immunology 99:229

    Article  CAS  PubMed  Google Scholar 

  11. Takahashi T, Nieda M, Koezuka Y, Nicol A, Porcelli SA, Ishikawa Y, Tadokoro K, Hirai H, Juji T (2000) Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 164:4458

    CAS  PubMed  Google Scholar 

  12. Hagihara M, Gansuvd B, Ueda Y, Tsuchiya T, Masui A, Tazume K, Inoue H., Kato S, Hotta T. (2002) Killing activity of human umbilical cord blood derived TCRValpha 24+ NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells. Cancer Immunol Immunother 51:1

    Article  CAS  PubMed  Google Scholar 

  13. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nishimura T (1999) The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 189:1121

    CAS  PubMed  Google Scholar 

  14. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, Kondo E, Harada M, Koseki H, Nakayama T, Tanaka Y, Taniguchi M (1998) Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci USA 95:5690

    Article  CAS  PubMed  Google Scholar 

  15. Eberl G., MacDonald HR (2000) Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 30:985

    Article  CAS  PubMed  Google Scholar 

  16. Ishihara S, Nieda M, Kitayama J, Osada T, Yabe T, Kikuchi A, Koezuka Y, Porcelli SA, Tadokoro K, Nagawa H, Juji T (2000) Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3CD56+ NK cells in vitro. J Immunol 165:1659

    CAS  PubMed  Google Scholar 

  17. Gluckman E, Rocha V, Chastang C (1999) Cord Blood stem cell transplantation. Baillieres Best Pract Res Clin Haematol 12:279

    Article  CAS  PubMed  Google Scholar 

  18. Sanz MA, Sanz GF (2002) Unrelated donor umbilical cord blood transplantation in adults. Leukemia 16:1984

    Article  CAS  Google Scholar 

  19. El Marsafy S, Dosquet C, Coudert M-C, Bensussan A, Carosella E, Gluckman E (2001) Study of cord blood natural killer cells suppressor activity. Eur J Haematol 66:215

    Article  PubMed  Google Scholar 

  20. Nomura A, Takeda H, Jin CH, Tanaka T, Ohga S, Hara T (2001) Functional analyses of cord blood killer cells and T cells: a distinctive interleukin-18 response. Exp Hematol 29:1169

    Article  CAS  PubMed  Google Scholar 

  21. Webb BJ, Bochan MR, Montel A, Padilla LM, Brahmi Z (1994) The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol 159:246

    CAS  PubMed  Google Scholar 

  22. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245

    CAS  PubMed  Google Scholar 

  23. Poggi A, Carosio R, Spaggiari GM, Fortis C, Tambussi G, Dell'Antonio G, Dal Cin E, Rubartelli A, Zocchi MR (2002) NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain. J Immunol 168:95

    CAS  PubMed  Google Scholar 

  24. Yu Y, Hagihara M, Ando K, Gansuvd B, Matsuzawa H, Tsuchiya T, Ueda Y, Inoue H, Hotta T, Kato S (2001) Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J Immunol 166:1590

    CAS  PubMed  Google Scholar 

  25. Exley M, Garcia J, Wilson SB, Spada F, Gerdes D, Tahir SM, Patton KT, Blumberg RS, Porcelli S, Chott A, Balk SP (2000) CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 100:37

    Article  CAS  PubMed  Google Scholar 

  26. Hameg A, Apostolou I, Leite-de-Moraes M, Gombert J-M, Garcia C, Kowzuka Y, Bach J-F, Herbelin A (2000) A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the α-galactosylceramide antigen. J Immunol 165:4917

    CAS  PubMed  Google Scholar 

  27. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN (2002) Characterization of human blood dendritic cell subsets. Blood 100:4512

    Article  CAS  PubMed  Google Scholar 

  28. Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Schueller G, Zontsich T, Benkoe T, Radelbauer K, Brostjan C, Jakesz R, Gnant M (2003) Dendritic cell-based vaccination in solid cancer. J Clin Oncol 21:135

    Article  CAS  PubMed  Google Scholar 

  29. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2:52

    CAS  PubMed  Google Scholar 

  30. Okai M, Nieda M, Tazbirkova A, Horley D, Kikuchi A, Durrant S, Takahashi T,. Boyd A, Abraham R, Yagita H, Juji T, Nicol A (2002) Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. Vox Sang 83:250

    Article  CAS  PubMed  Google Scholar 

  31. van der Vliet HJJ, Nishi N, de Gruiji TD, von Blomenberg BME, van den Eertwegh AJM, Pinedo HM, Giaccone G., Scheper RJ (2000) Human natural killer T cells acquire a memory-activated phenotype before birth. Blood 95:2440

    PubMed  Google Scholar 

  32. Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T, Koezuka Y, Porcelli SA, Cardell S, Brenner MB, Behar SM. (2000) Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211

    CAS  PubMed  Google Scholar 

  33. Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA, Lanier LL, Liu YJ (2001) Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med 193:1221

    CAS  PubMed  Google Scholar 

  34. Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y, Van Kaer L (1999) Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 163:2373

    CAS  PubMed  Google Scholar 

  35. Fujii S, Shimizu K, Kronenberg M, Steinman RM (2002) Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol 3:867

    Article  CAS  PubMed  Google Scholar 

  36. Mosca PJ, Hobeika AC, Clay TM, Nair SK, Thomas EK, Morse MA, Lyerly HK (2000) A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-γ treatment. Blood 96:3499

    CAS  PubMed  Google Scholar 

  37. Tomura M, Yu WG., Ahn HJ, Yamashita M, Yang YF, Ono S, Hamaoka T, Kawano T, Taniguchi M, Koezuka Y, Fujiwara H (1999) A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol 163:93

    CAS  PubMed  Google Scholar 

  38. Nakagawa R, Nagafune I., Tazunoki Y, Ehara H, Tomura H, Iijima R, Motoki K, Kamishohara M, Seki S (2001) Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J Immunol 166:6578

    CAS  PubMed  Google Scholar 

  39. Seino K, Fukao K, Muramoto K, Yanagisawa K, Takad Y, Kakuta S, Iwakura Y, Van Kaer L, Takeda K, Nakayama T, Taniguchi M, Bashuda H., Yagita H, Okumura K (2001) Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 98:2577

    CAS  PubMed  Google Scholar 

  40. Ito K, Karasawa M, Kawano T, Akasaka T, Koseki H, Akutsu Y, Kondo E, Sekiya S, Sekikawa K, Harada M, Yamashita M, Nakayama T, Taniguchi M (2000) Involvement of decidual Valpha14 NKT cells in abortion. Proc Natl Acad Sci USA 97:740

    Article  CAS  PubMed  Google Scholar 

  41. Hammond K, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG. (1998) alpha/beta-T cell receptor (TCR)+CD4CD8 (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 187:1047

    CAS  PubMed  Google Scholar 

  42. Baxter AG., Kinder SJ, Hammond KJ, Scollay R, Godfrey DI. (1997) Association between alphabetaTCR+CD4-CD8 T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46:572

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by Health and Labor Sciences Research Grants, Research on Pharmaceutical and Medical Safety, and the Japanese Health Sciences Foundation, Research on Health Sciences focusing on Drug Innovation. We particularly wish to thank Dr William J Hubbard (University of Alabama at Birmingham, AL, USA) for comments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masao Hagihara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ueda, Y., Hagihara, M., Gansuvd, B. et al. The effects of αGalCer-induced TCRVα24 Vβ11+ natural killer T cells on NK cell cytotoxicity in umbilical cord blood. Cancer Immunol Immunother 52, 625–631 (2003). https://doi.org/10.1007/s00262-003-0398-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-003-0398-3

Keywords

Navigation